- Home
- ISD vs EBS Comparison
ISD vs EBS Comparison
Compare ISD & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ISD | EBS |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 426.8M | 413.3M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | ISD | EBS |
|---|---|---|
| Price | $12.58 | $4.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 130.8K | ★ 898.0K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | ★ 9.69% | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | N/A | $1.29 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.31 | $4.81 |
| 52 Week High | $14.79 | $14.06 |
Technical Indicators
Market Signals| Indicator | ISD | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 45.44 | 16.36 |
| Support Level | $12.57 | N/A |
| Resistance Level | $12.85 | $8.73 |
| Average True Range (ATR) | 0.16 | 0.33 |
| MACD | 0.02 | -0.29 |
| Stochastic Oscillator | 49.07 | 0.74 |
Price Performance
Historical ComparisonAbout ISD PGIM High Yield Bond Fund Inc.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.